Ruifang Wu Selected Research

Ruifang Wu Research Topics

Disease

12	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 01/2018
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 05/2009
6	Uterine Cervical Dysplasia 01/2021 - 05/2009
5	Neoplasms (Cancer) 01/2022 - 04/2010
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 01/2018
3	Squamous Intraepithelial Lesions 03/2024 - 05/2009
3	Dermatitis 01/2023 - 02/2020
3	Wilms Tumor (Wilm's Tumor) 07/2021 - 10/2018
2	Papillomavirus Infections 02/2024 - 01/2022
2	Infections 10/2023 - 01/2022
2	Inflammation (Inflammations) 07/2023 - 01/2018
2	Metaplasia 07/2023 - 01/2023
2	Pemphigus (Pemphigus Vulgaris) 04/2023 - 01/2023
2	Iron Overload 01/2023 - 10/2021
2	Endometriosis 10/2021 - 10/2017
2	Hemorrhage 01/2021 - 01/2019
1	Arthritis (Polyarthritis) 09/2023
1	Endometrial Neoplasms (Endometrial Cancer) 07/2023
1	malar rash 04/2023
1	Autoimmune Diseases (Autoimmune Disease) 04/2023
1	Communicable Diseases (Infectious Diseases) 04/2023
1	Exanthema (Rash) 04/2023
1	Lupus Nephritis 04/2023
1	Interstitial Pregnancy 02/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2023
1	Bullous Pemphigoid (Pemphigoid) 01/2023
1	Pre-Eclampsia (Preeclampsia) 01/2023
1	Krukenberg Tumor 01/2023
1	Cicatrix (Scar) 01/2023
1	Corneal Opacity 11/2022
1	Psoriatic Arthritis 10/2022
1	Proteinuria 03/2022
1	Dermatomyositis (Dermatopolymyositis) 03/2022
1	Primary Ovarian Insufficiency 01/2022
1	Infertility (Sterility) 11/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Pain (Aches) 01/2021
1	Vaginal Discharge 01/2021
1	COVID-19 11/2020
1	Obesity 09/2019
1	Leiomyoma (Uterine Fibroids) 01/2019

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 09/2023 - 01/2022
4	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 01/2018
3	InterferonsIBA 01/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 10/2018
3	Histones (Histone)IBA 03/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 11/2020 - 11/2010
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2024 - 02/2024
2	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 08/2010
2	IronIBA 01/2023 - 10/2021
2	Indicators and Reagents (Reagents)IBA 06/2022 - 11/2021
2	VaccinesIBA 01/2022 - 01/2022
2	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 11/2017
2	Transcription Factors (Transcription Factor)IBA 07/2021 - 10/2018
1	Circular RNAIBA 10/2023
1	Molecular Motor ProteinsIBA 10/2023
1	Bacterial ToxinsIBA 10/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2023
1	AutoantibodiesIBA 04/2023
1	Methotrexate (Mexate)FDA LinkGeneric 02/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	LipidsIBA 01/2023
1	InterleukinsIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	CytokinesIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Nucleosomes (Nucleosome)IBA 03/2022
1	Iodide Peroxidase (Deiodinase)IBA 01/2022
1	Thyroglobulin FDA Link 01/2022
1	Combined VaccinesIBA 01/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022
1	AntigensIBA 01/2022
1	GonadotropinsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Infliximab (Remicade)FDA Link 11/2020
1	Nuclear Proteins (Protein, Nuclear)IBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	N-methyladenosineIBA 11/2020
1	ORALIT (ORS)IBA 10/2020
1	HDL LipoproteinsIBA 02/2020
1	AdipokinesIBA 09/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2020
2	Photochemotherapy (Photodynamic Therapy) 03/2024 - 02/2024
2	Intradermal Injections 01/2023 - 01/2018
2	Slit Lamp 01/2023 - 11/2022
2	Lasers (Laser) 01/2019 - 06/2014
2	Hysterectomy 01/2019 - 01/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023
1	Cesarean Section (Caesarean Section) 01/2023
1	Electrocoagulation (Electrocautery) 01/2021
1	Duration of Therapy 01/2021
1	Cryotherapy (Therapy, Cold) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Topical Administration 02/2020